Press Releases for GNBT

Press Releases
Ridgewater Equity Trend and Financial Analysis of Generex Biotechnology Corp., Allscripts-Misys Healthcare Solutions Inc., Lexicon Pharmaceuticals Inc., ATP Oil & Gas Corp., TeleCommunication Systems Inc. and Charming Shoppes Inc.
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
StockPreacher.Com Issues Trading Outlook for Novadel Pharma Inc.
Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead By ImmunoCellular Therapeutics
New Cancer Immunotherapy Index Posts 23% Gains Lead By Mentor Capital, Inc. And Oncothyreon
Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference
Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine
Generex Announces Sales Agreement With McCarthy and Sons Service
Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock
Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
Amgen Co-Founder to Act As Generex Chief Scientific Advisor; Generex Engages Dr. Joseph Rubinfeld to Spearhead the Company's Scientific Development and Commercialization Plans for Its Drug Delivery Platform and Vaccine Technologies
Amgen Co-founder to Act as Generex Chief Scientific Advisor
Generex Reports Annual Meeting Resulted in Shareholders Passing All Proxy Proposals With Strong Support
Generex Announces Plans to File An Investigational New Drug (IND) With the Veterinary Drugs Directorate of Health Canada in Anticipation of a New Drug Submission for Generex Oral-lyn(tm)
Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine for HPV-Induced Cervical Cancer
Generex Sees Favorable Results From MetControl(tm) Chewing Gum Bio-equivalency Study Leading to Global Product Submissions
Generex's New Vaccine Technology Could Speed Flu Vaccine Availability
Generex Expands Company Commercialization Plans and Names Stephen Fellows Vice President of Finance
Generex Provides Update On North American Retail Broker Network; Company Aligning Broker Network With Customer Base
Generex Provides Update On North American Retail Broker Network
Generex Biotechnology Raises $11 Million in a Registered Direct Offering of Common Stock
Generex Biotechnology Announces Intention to Complete a Registered Direct Offering of Common Stock
Generex Awarded Five New Patents for Its Proprietary Drug Delivery Systems; Company Expands Patent Protection in Canada, Australia, New Zealand, Brazil and Lebanon
Generex Awarded Five New Patents for Its Proprietary Drug Delivery Systems
GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN
Generex Data Presented At The Endocrine Society's Annual Meeting
Generex Retires 8% Senior Secured Convertible Notes; Company Now Entitled to the Return of Its $3,000,000 in Cash Collateral
Generex Retires 8% Senior Secured Convertible Notes
Generex Presented Positive Study Data At the American Diabetes Association Scientific Sessions
Generex to Present Positive Study Data At American Diabetes Association Scientific Sessions 2009
Generex Presents Positive Results of Phase 1 Prostate Cancer Vaccine Trial At the American Society of Clinical Oncology
Generex Scientist to Participate in Panel Discussion At Swine Influenza Symposium
Generex Biotechnology Presents Platform Vaccine Technology At International Congress of Antibodies
Generex Comments on Recent Stock Offering
Generex Biotechnology Announces Consummation of $5 Million Registered Direct Offering of Common Stock
Generex Launches Commercial Sales of Oral Insulin in Lebanon
MaybachFinancial.Com Posts Free Analyst Report on HNT, IVN, GNBT and CTXS
Generex Announces Educational Lecture on Oral Insulin at Hamad General Hospital in Qatar
Generex Receives Regulatory Approval to Sell Generex Oral-lyn(tm) in Algeria
Antigen Express President Interviewed About Company's Vaccine Technology Platform and Swine Flu Virus
Generex Awarded New Patent in Morocco; Company Augments International Patent Portfolio
Generex Awarded New Patent in Morocco
Generex Announces Presentation Held At NMC Specialty Hospital, Abu Dhabi
Generex to Pursue Regulatory Path for Application of Generex Oral-lyn(tm) for Veterinary Market
Generex Biotechnology CEO Anna Gluskin Featured On FOX Business Network
Generex Oral-lyn(tm) Study Results Scheduled for Podium Presentation at 69th American Diabetes Association Scientific Sessions
Generex Biotechnology to Hold Conference Call On Friday to Update Investors On Phase III Trial of Generex Oral-lyn(tm) and Other Corporate Activities
Generex Biotechnology Provides Update On Generex Oral-lyn(tm) in India
Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
Generex Oral-lyn™ to be presented at International Conference on Advances in Diabetes and Insulin Therapy
Note to A-Rod: BaBOOM!™ is Legal and We’ll Give It to You for Free
Generex Announces Launch of Crave-NX(tm) 7-Day Diet Aid Spray
Generex Biotechnology Receives US$500,000 Purchase Order; Company's Middle Eastern Branch Office Begins Shipping Order to Saudi Arabian Distributor
Generex Biotechnology Receives US$500,000 Purchase Order
Generex Announces Participation in 2009 Arab Health Congress
Generex Announces Distribution Agreement With Butler Animal Health Supply
Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Studies
Generex Announces Governmental Approval of its Oral Insulin Spray Product in Lebanon
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
Generex Awarded New Patent in Europe
Generex Biotechnology Update On Novel Immunotherapeutic Vaccine to be Presented At San Antonio Breast Cancer Symposium
Generex Announces Positive Results of Metformin Chewing Gum Trial
Generex Updates On Press Coverage of Generex Oral-lyn(tm) Commercial Launch in India
Generex Awarded New Pain Relief Patents
Photo Release -- Generex Launches Oral Insulin for Diabetes Management in India; Retail Availability Coincides With World Diabetes Day
CORRECTION -- Generex Biotechnology to Make Convertible Debenture Payment in Cash
Generex Biotechnology to Make Convertible Debenture Payment in Cash
Generex Biotechnology Corporation's Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC
Generex Oral-lyn(tm) Featured On XM Satellite Radio
Generex Biotechnology Submits Syrian Dossier
Generex Oral-lyn Featured at International Diabetes Conference
Generex Biotechnology Comments On New ADA/EASD Consensus Algorithm for Type 2 Diabetes Treatment
Generex to Host Satellite Symposium At World Congress on Controversies to Consensus in Diabetes, Obesity & Hypertension
Generex Biotechnology Awarded New Drug Delivery Patent
Generex Biotechnology Granted Additional Time to Comply With Nasdaq Marketplace Rule 4310(c)(4)
Generex Announces Enrollment of Initial Subjects in Metformin Gum Trial
Generex Biotechnology to Present At 2008 BioNetwork Conference
Generex Biotechnology Corp. Announces Cancelled Trades
Generex Announces Enrollment of More Than Two Hundred Subjects in Generex Oral-lyn Phase III Trial
Generex Biotechnology to Present Abstracts at Scientific Symposium
Generex Biotechnology to Sponsor International Diabetes Symposium in Rome
Generex CEO Interview With Business News Network Available Online
Generex Biotechnology Signs Oral Insulin Distribution Deal for Korea
Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in Brazil
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
Generex Announces Enrollment of Over 150 Patients in Phase III Trial of Generex Oral-lyn
Generex Biotechnology Comments On Recent Trading Activity
Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology's Novel Immunotherapeutic Vaccine
Generex Biotechnology to Commence Generex Oral-lyn Trial Involving Subjects With Impaired Glucose Tolerance
Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
Generex Biotechnology Granted Additional Time to Comply With NASDAQ Listing Requirement
Generex Biotechnology Featured on FOXNews.com
Generex Biotechnology Sponsors Generex Oral-lyn Education & Training Symposium in Middle East
Generex Biotechnology Generates New Sales of Approximately $300,000 Through the Generex MENA Office Located in Dubai Healthcare City Center
Generex to Present Data At the 35th Annual Meeting & Exposition of the Controlled Release Society
Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies
A Shot in the Arm Against Breast Cancer
Generex Biotechnology Presented Data At The Endocrine Society's Annual Meeting
Generex Biotechnology Corporation to Hold Conference Call On Tuesday, June 24th to Update Investors On Phase III Trial of Generex Oral-lyn and Other Corporate Activities